Why the study?
Do PPARγ activators inhibit cardiac hypertrophy in neonatal rat cardiac myocytes?
Population
Neonatal rat cardiac myocytes
Comparison
PPARγ activators at 10 μmol/L vs Control under cyclic 4% biaxial mechanical…
Design
Preclinical
Authors
Loading...
Hypothesis-generating for PPARγ activators limiting myocyte hypertrophy; leaves open translation to in vivo or clinical settings.
Do PPARγ activators inhibit cardiac hypertrophy in neonatal rat cardiac myocytes?
PPARγ activators inhibit mechanically and agonist-induced cardiac hypertrophy in neonatal rat cardiac myocytes, potentially via the NF-κB pathway.
Yamamoto et al. (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: